Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs

A.A.M. van der Veldt; J.M. Lubberink; I. Bahce; M. Walraven; M.P. de Boer; H.N.J.M. Greuter; N.H. Hendrikse; P.A.J. Eriksson; A.D. Windhorst; P.E. Postmus; H.M.W. Verheul; E.H. Serné; A.A. Lammertsma; E.F. Smit

doi:10.1016/j.ccr.2011.11.023

Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs

A.A.M. van der Veldt, J.M. Lubberink, I. Bahce, M. Walraven, M.P. de Boer, H.N.J.M. Greuter, N.H. Hendrikse, P.A.J. Eriksson, A.D. Windhorst, P.E. Postmus, H.M.W. Verheul, E.H. Serné, A.A. Lammertsma, E.F. Smit

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	82-91
Journal	Cancer Cell
Volume	21
Issue number	1
DOIs	https://doi.org/10.1016/j.ccr.2011.11.023
Publication status	Published - 2012

Access to Document

10.1016/j.ccr.2011.11.023

Cite this

van der Veldt, A. A. M., Lubberink, J. M., Bahce, I., Walraven, M., de Boer, M. P., Greuter, H. N. J. M., Hendrikse, N. H., Eriksson, P. A. J., Windhorst, A. D., Postmus, P. E., Verheul, H. M. W., Serné, E. H., Lammertsma, A. A., & Smit, E. F. (2012). Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs. Cancer Cell, 21(1), 82-91. https://doi.org/10.1016/j.ccr.2011.11.023

van der Veldt, A.A.M. ; Lubberink, J.M. ; Bahce, I. ; Walraven, M. ; de Boer, M.P. ; Greuter, H.N.J.M. ; Hendrikse, N.H. ; Eriksson, P.A.J. ; Windhorst, A.D. ; Postmus, P.E. ; Verheul, H.M.W. ; Serné, E.H. ; Lammertsma, A.A. ; Smit, E.F. / Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs. In: Cancer Cell. 2012 ; Vol. 21, No. 1. pp. 82-91.

@article{eaa9ede486aa409aae11b3dd9f4ffd24,

title = "Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs",

author = "{van der Veldt}, A.A.M. and J.M. Lubberink and I. Bahce and M. Walraven and {de Boer}, M.P. and H.N.J.M. Greuter and N.H. Hendrikse and P.A.J. Eriksson and A.D. Windhorst and P.E. Postmus and H.M.W. Verheul and E.H. Sern{\'e} and A.A. Lammertsma and E.F. Smit",

year = "2012",

doi = "10.1016/j.ccr.2011.11.023",

language = "Undefined/Unknown",

volume = "21",

pages = "82--91",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "1",

}

van der Veldt, AAM, Lubberink, JM, Bahce, I , Walraven, M, de Boer, MP, Greuter, HNJM, Hendrikse, NH, Eriksson, PAJ, Windhorst, AD, Postmus, PE, Verheul, HMW , Serné, EH , Lammertsma, AA & Smit, EF 2012, 'Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs', Cancer Cell, vol. 21, no. 1, pp. 82-91. https://doi.org/10.1016/j.ccr.2011.11.023

Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs. / van der Veldt, A.A.M.; Lubberink, J.M.; Bahce, I.; Walraven, M.; de Boer, M.P.; Greuter, H.N.J.M.; Hendrikse, N.H.; Eriksson, P.A.J.; Windhorst, A.D.; Postmus, P.E.; Verheul, H.M.W.; Serné, E.H.; Lammertsma, A.A.; Smit, E.F.

In: Cancer Cell, Vol. 21, No. 1, 2012, p. 82-91.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs

AU - van der Veldt, A.A.M.

AU - Lubberink, J.M.

AU - Bahce, I.

AU - Walraven, M.

AU - de Boer, M.P.

AU - Greuter, H.N.J.M.

AU - Hendrikse, N.H.

AU - Eriksson, P.A.J.

AU - Windhorst, A.D.

AU - Postmus, P.E.

AU - Verheul, H.M.W.

AU - Serné, E.H.

AU - Lammertsma, A.A.

AU - Smit, E.F.

PY - 2012

Y1 - 2012

U2 - 10.1016/j.ccr.2011.11.023

DO - 10.1016/j.ccr.2011.11.023

M3 - Article

VL - 21

SP - 82

EP - 91

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 1

ER -